Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03878043
Recruitment Status : Completed
First Posted : March 18, 2019
Last Update Posted : March 21, 2019
Sponsor:
Information provided by (Responsible Party):
Tarik Wasfie, MD, Genesys Regional Medical Center

Brief Summary:
Acute traumatic subdural hematomas (TSDH) readmission rate is high (27.8%) with an increase in morbidity and cost for the elderly. This study identifies risk factors affecting readmission rates for these patients and presents strategies to reduce it.

Condition or disease Intervention/treatment
Traumatic Subdural Hematoma Other: Follow-up Care

Detailed Description:
A retrospective analysis was conducted on patients with traumatic brain injuries (ICD-9-CM codes 800.20 - 801.86, 852.00 - 853.05) admitted between 2014 and 2016 at Genesys Regional Medical Center through the trauma service. From this group, the investigators selected patients admitted with traumatic SDH, and those patients were followed over the following 6 months as regards to readmission status. Patients who were readmitted versus patients who were not readmitted were compared. The risk of readmission within 6 months of discharge for SDH was analyzed adjusting for age, prior anticoagulation use, Injury Severity Score (ISS), Glasgow Coma Scale (GCS), gender, time to readmission and co-morbid conditions which included diabetes mellitus, cardiovascular disease, renal disease, chronic obstructive pulmonary disease, and osteoporotic/orthopedic fractures using Cox Proportional Hazards Regression analysis.

Layout table for study information
Study Type : Observational
Actual Enrollment : 167 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Retrospective Analysis of Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly
Actual Study Start Date : January 2014
Actual Primary Completion Date : December 2016
Actual Study Completion Date : March 2019

Group/Cohort Intervention/treatment
Patients without Readmissions
Patients with TSDH who were not readmitted within a 6-month time period following their initial visit.
Patients with Readmissions
Patients with TSDH who were readmitted within a 6-month time period following their initial visit.
Other: Follow-up Care
Follow up care provided upon readmission to patients who were diagnosed with a TSDH upon initial visit.




Primary Outcome Measures :
  1. Number of participants readmitted to the hospital [ Time Frame: 6 months ]
    Number of patients diagnosed with TSDH who were readmitted to the hospital within a 6 month time frame



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 105 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients admitted to a Community General Hospital who were diagnosed with a Traumatic Subdural Hematoma.
Criteria

Inclusion Criteria:

  • Patients diagnosed with Traumatic Subdural Hematoma during time of study

Exclusion Criteria:

  • Patients who expired.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03878043


Locations
Layout table for location information
United States, Michigan
Genesys Regional Medical Center
Grand Blanc, Michigan, United States, 48439
Sponsors and Collaborators
Tarik Wasfie, MD
Investigators
Layout table for investigator information
Principal Investigator: Tarik Wasfie, MD Genesys Regional Medical Center

Layout table for additonal information
Responsible Party: Tarik Wasfie, MD, Professor, Department of Trauma Surgery, Genesys Regional Medical Center
ClinicalTrials.gov Identifier: NCT03878043     History of Changes
Other Study ID Numbers: GRMC 160013
First Posted: March 18, 2019    Key Record Dates
Last Update Posted: March 21, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Tarik Wasfie, MD, Genesys Regional Medical Center:
subdural hematoma
readmission
risk factors
Additional relevant MeSH terms:
Layout table for MeSH terms
Hematoma, Subdural
Hematoma, Subdural, Intracranial
Hematoma
Hemorrhage
Pathologic Processes
Intracranial Hemorrhage, Traumatic
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Vascular Diseases
Cardiovascular Diseases
Wounds and Injuries